Skip to content

Clinical trials

Lung Neoplasms trials in France with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Not applicable Country / region: France Clear all

106 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20072
20082
20092
20101
20113
20126
20132
20144
20158
20168
20173
20185
20194
20205
202113
20228
20236
202411
20254
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed54
Recruiting24
Unknown status9
Terminated8
Not yet recruiting5
Active, not recruiting4
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris8
Hospices Civils de Lyon6
Assistance Publique Hopitaux De Marseille4
Centre Leon Berard4
University Hospital, Limoges4
Centre Chirurgical Marie Lannelongue3
Centre Georges Francois Leclerc3
Centre Henri Becquerel3
Centre Hospitalier Universitaire de Besancon3
Centre Hospitalier Universitaire de Nice3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms106
Carcinoma, Non-Small-Cell Lung20
Breast Neoplasms17
Colorectal Neoplasms9
Prostatic Neoplasms9
Neoplasms8
Head and Neck Neoplasms6
Neoplasm Metastasis6
Brain Neoplasms5
Colonic Neoplasms5

Trials

Showing 1 to 25 of 106. Each trial links to its page on Pharma Observatory.

6 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.